Ischemic strokes accounting for 82% of cases, the need for targeted treatments is critical. An aging population and increased risk factors like hypertension further drive demand, offering a ...
Sportschosun on MSN
Myocardial infarction → cerebral infarction..Eighty-five-year-old Samija is over life and death I hear there's no chance
Actor Samija carefully confessed the health problems she suffered three years ago.On the 15th, TV Chosun program "Perfect ...
Endovascular thrombectomy for pediatric stroke due to M2 occlusion is linked to greater functional or neurologic outcomes ...
Brain aneurysms are among the most frightening and unexpected medical situations. Because they often display no symptoms ...
While winter brings with it foggy mornings, festivals and comfort, With the lowering of temperature and the onset of winter, ...
WISN 12 Milwaukee on MSN
The year in review. A look at 2025's top stories
The year 2025 is nearly at its end, and what a year it has been. We've seen tragedy, triumph, terror and celebration all ...
Primary care physicians are often the first to notice transient ischemic attack stroke symptoms or risks. The right questions can help determine next steps.
A new study identifies molecular factors that promote small vessel disease – and an active drug that can restore impaired vascular functions.
Live Science on MSN
Diagnostic dilemma: An otherwise 'fit' man had a stroke after drinking 8 'high-potency' energy drinks a day
"Further follow-up at 3 and 6 months showed complete resolution of hypertension and a complete recovery from the stroke with ...
Chronic cerebral arterial occlusion and moyamoya disease are significant causes of stroke, particularly in regions where ...
Sportschosun on MSN
Professor Kim Jae-hoon, an authority on cerebrovascular and oncology surgery, was appointed as the n...
Professor Kim Jae-hoon (54) of neurosurgery will be inaugurated as the 20th hospital director of Nowon Eulji University ...
Pfizer (PFE) stock in red as the company reports a patient death in a clinical trial for its hemophilia therapy Hympavzi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results